Dexmedetomidine Versus Magnesium Sulfate Infusion in Craniotomy

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 20, 2025

Primary Completion Date

October 1, 2026

Study Completion Date

November 1, 2026

Conditions
Craniotomy Surgery
Interventions
DRUG

Dexamedomedine

"Group A (the Dexmedetomidine group):~Dexmedetomidine: loading dose 1 µg/kg IV over 10 min after induction and then maintenance dose 0.2- 0.7 µg/kg/hr based on hemodynamic response."

DRUG

MgSO4

Magnesium Sulfate: Used as an IV loading dose at 20 mg/kg IV over 17 minutes as an induction agent, followed by maintenance of 10 mg/kg/h

All Listed Sponsors
lead

Assiut University

OTHER

NCT07199595 - Dexmedetomidine Versus Magnesium Sulfate Infusion in Craniotomy | Biotech Hunter | Biotech Hunter